GLP-1 receptor agonists enhance insulin secretion and suppress glucagon in a glucose-dependent manner
This process is called endogenous synthesis, or the bodys internal manufacturing process
Pain during injection is influenced by several factors, including the amount of fat in the area, the presence of nerve endings, and how deeply the needle is inserted
At the same time, he recommends all his patients on GLP-1s up their protein intake to "the maximum" recommended dose, and incorporate more movement into their daily routines, to help safeguard their musculature and prioritize fat loss over muscle wasting as they eat less food
In support of this notion, subcutaneously administered LUXendin645, an Ex9based GLP1 receptor antagonist, has been demonstrated to have an overlapping distribution with PPG axons in the arcuate nucleus (Ast et al., 2020)